Cited by 757Peptidase Inhibition and AnalysisImmune cells in cancerTGF-β signaling in diseases

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling

Yang, Xuguang, Lin, Yuli, Shi, Yinghong, Li, Bingji, Liu, Weiren, Yin, Wei, Dang, Yongjun, Chu, Yiwei, Fan, Jia, He, Rui·2016·Cancer Research

DOI 10.1158/0008-5472.can-15-2973

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Cancer-associated fibroblasts (CAF) are components of the tumor microenvironment whose contributions to malignant progression are not fully understood. Here, we show that the fibroblast activation protein (FAP) triggers induction of a CAF subset with an inflammatory phenotype directed by STAT3 activation and inflammation-associated expression signature marked by CCL2 upregulation. Enforcing FAP expression in normal fibroblasts was sufficient to endow them with an inflammatory phenotype similar to FAP(+)CAFs. We identified FAP as a persistent activator of fibroblastic STAT3 through a uPAR-dependent FAK-Src-JAK2 signaling pathway. In a murine liver tumor model, we found that FAP(+)CAFs were a major source of CCL2 and that fibroblastic STAT3-CCL2 signaling in this setting promoted tumor growth by enhancing recruitment of myeloid-derived suppressor cells (MDSC). The CCL2 receptor CCR2 was expressed on circulating MDSCs in tumor-bearing subjects and FAP(+)CAF-mediated tumor promotion and MDSC recruitment was abrogated in Ccr2-deficient mice. Clinically, we observed a positive correlation between stromal expression of FAP, p-STAT3, and CCL2 in human intrahepatic cholangiocarcinoma, a highly aggressive liver cancer with dense desmoplastic stroma, where elevated levels of stromal FAP predicted a poor survival outcome. Taken together, our results showed how FAP-STAT3-CCL2 signaling in CAFs was sufficient to program an inflammatory component of the tumor microenvironment, which may hav…

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-15-2973

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer-related inflammation
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Fibroblasts in cancer
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085

Show all 44 references

Sorted by citations

Items 501–600 of 757

Investigating the effect of Fusobacterium nucleatum on the aggressive behavior of cancer-associated fibroblasts in colorectal cancer
Eskandari-Malayeri, F., Rezeai, M., Narimani, T., Esmaeil, N., & Azizi, M. (2024) · Discover Oncology · doi:10.1007/s12672-024-01156-0 · Cited by 9
Application of nanotechnology in the treatment of hepatocellular carcinoma
Cai, L., Du, Y., Xiong, H., & Zheng, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1438819 · Cited by 9
Effects of FAP+ fibroblasts on cell proliferation migration and immunoregulation of esophageal squamous carcinoma cells through the CXCL12/CXCR4 axis
Duan, L., Cao, S., Zhao, F., Du, X., Gao, Z., Wang, X., & Bian, F. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05226-x · Cited by 9
Interactions in hepatic tumor microenvironment: Potential targets and modulations for effective therapy
Altalbawy, F. M. A., Zwamel, A. H., Sanghvi, G. V., Roopashree, R., Kumari, M., Kashyap, A., S, G. S., & Panigrahi, R. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156074 · Cited by 9
Expanding the Horizon of Targeted Radionuclide Therapy: Immunotherapy Combinations and FAP-Targeted Approaches
Öztürk, A. A., Delbart, W., & Flamen, P. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.08.003 · Cited by 10
ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
Summers, S. E., Salih, V. M., & Foey, A. (2023) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2023.1116402 · Cited by 9
Disruption of LPA‐LPAR1 pathway results in lung tumor growth inhibition by downregulating B7‐H3 expression in fibroblasts
Meng, F., Yin, Z., Lu, F., Wang, W., & Zhang, H. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15193 · Cited by 9
CAF-derived exosomal miR-196b-5p after androgen deprivation therapy promotes epithelial-mesenchymal transition in prostate cancer cells through HOXC8/NF-κB signaling pathway
Song, X., Li, T., Zhou, W., Feng, C., Zhou, Z., Chen, Y., Deng, L., Chen, L., Zhao, J., Zhang, Y., et al. (2025) · Biology Direct · doi:10.1186/s13062-025-00667-2 · Cited by 9
Elevated CXCL12 in the plasma membrane of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a potential prognostic marker
Kim, S., Yeo, M., Kim, J.-S., Kim, J., & Kim, K. (2021) · Journal of Cancer · doi:10.7150/jca.64082 · Cited by 9
TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance
Liu, Z., Zhang, C., Xiao, J., He, Y., Liang, H., Huang, J., Cai, Z., Yi, Z., Chen, M., Li, Y., et al. (2025) · Theranostics · doi:10.7150/thno.103175 · Cited by 8
Fibroblast activation protein (FAP) as a prognostic biomarker in multiple tumors and its therapeutic potential in head and neck squamous cell carcinoma
Li, R., NAN, X., Li, M., & Rahhal, O. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.046965 · Cited by 8
Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-TGFβ axis and immune suppression in aggressive thyroid cancer
Udinotti, M., Siebolts, U., Bauer, M., Vaxevanis, C., Asiminas, A., Lorenz, K., Dierks, C., Wickenhauser, C., & Seliger, B. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07307-3 · Cited by 8
Single-Cell Sequencing Unravels Pancreatic Cancer: Novel Technologies Reveal Novel Aspects of Cellular Heterogeneity and Inform Therapeutic Strategies
Chen, K., Chen, Z., Wang, J., Zhou, M., Liu, Y., Xu, B., Yu, Z. H., Li, Y., Yang, G., & Xu, T. (2025) · Biomedicines · doi:10.3390/biomedicines13123024 · Cited by 8
Identification of fibroblast-related genes based on single-cell and machine learning to predict the prognosis and endocrine metabolism of pancreatic cancer
Xu, Y., Chen, X., Liu, N., Zhong, C., & Wang, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1201755 · Cited by 8
Modulation of Cancer-Associated Fibroblasts by Nanodelivery System to Enhance Efficacy of Tumor Therapy
Ai, W., Liu, T., Lv, C., Feng, X., & Wang, Q. (2023) · Nanomedicine · doi:10.2217/nnm-2023-0088 · Cited by 8
Association between high expression of intratumoral fibroblast activation protein and survival in patients with intrahepatic cholangiocarcinoma
Waki, Y., Morine, Y., Noma, T., Takasu, C., Teraoku, H., Yamada, S., Saito, Y., Ikemoto, T., & Shimada, M. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-03012-x · Cited by 8
New sights of immunometabolism and agent progress in colitis associated colorectal cancer
Zhang, J., Chen, C., Yan, W., & Fu, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1303913 · Cited by 10
Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies
Liu, Q., Yao, F., Wu, L., Xu, T., Na, J., Shen, Z., Liu, X., Shi, W., Zhao, Y., & Liao, Y. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03492-7 · Cited by 9
Decoding the complex web: cellular and molecular interactions in the lung tumour microenvironment
Issa, B. S., Adhab, A. H., Mahdi, M. S., Kyada, A., Ganesan, S., Bhanot, D., Naidu, K. S., Kaur, S., Mansoor, A. S., Radi, U. K., et al. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2445772 · Cited by 8
Effective design of therapeutic nanovaccines based on tumor neoantigens
Wang, W., Zhai, Y., Yang, X., Ye, L., Lu, G., Shi, X., & Zhai, G. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.078 · Cited by 8
Self-citation
Computational STAT3 activity inference reveals its roles in the pancreatic tumor microenvironment
Schaafsma, E., Yuan, Y., Zhao, Y., & Cheng, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-54791-x · Cited by 8
Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer
Aderonke, A. B., Ibrahim, R. B., & Huang, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184624 · Cited by 8
Subverting Attachment to Prevent Attacking: Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion
Mastrogiovanni, M., Donnadieu, E., Pathak, R., & Bartolo, V. D. (2024) · Biology · doi:10.3390/biology13110860 · Cited by 8
Baricitinib inhibits the activation of innate immune cells and exerts therapeutic effects on acute peritonitis and systemic inflammatory response syndrome
Hao, D., Luo, Y., Liao, H., Lu, Z., Huang, M., Du, M., Zhu, Z., & Qing, W. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113568 · Cited by 7
Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune‐Checkpoint Inhibitors
Gao, Q., Wu, H., Li, Z., Yang, Z., Li, L., Sun, X., Wu, Q., & Sui, X. (2025) · Phytotherapy Research · doi:10.1002/ptr.8482 · Cited by 7
Myeloid cells are involved in tumor immunity, metastasis and metabolism in tumor microenvironment
Zhang, C., Song, Y., Yang, H., & Wu, K. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10012-y · Cited by 8
Modulating the Immunosuppressive Tumor Microenvironment and Inhibiting Growth in Mutp53-Driven CRPC via STAT3 Pathway Blockade
Bian, Z., Chen, J., Wang, Y., Jin, C., Liang, C. Y., Meng, J., & Zhang, M. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.111732 · Cited by 8
Understanding the Cancer-Associated Fibroblast (CAF) and Its Biomarker Fibroblast Activation Protein (FAP), and Aspects in Human Liver Cancer
Qu, Y. A., Huang, J. C. N., Wang, Z. V., Ferguson, A. L., Nguyen, J. M. H. N., Zhang, M. N., Osborne, K., Boumelhem, B. B., McCaughan, G. W., Liu, K., et al. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl44837 · Cited by 8
Cancer-associated fibroblast targeting therapies as a tool to enhance responses to radiotherapy and immunotherapy
Garate-Soraluze, E., Martínez-Zubiaurre, I., & Rodriguez-Ruiz, M. E. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009702 · Cited by 8
The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts
Cadamuro, M., Nuozzi, G., Simioni, P., & Fabris, L. (2023) · Hepatoma Research · doi:10.20517/2394-5079.2023.94 · Cited by 8
SFRP1 mediates cancer-associated fibroblasts to suppress cancer cell proliferation and migration in head and neck squamous cell carcinoma
Dong, L., Li, Y., Song, X., Sun, C., & Song, X. (2024) · BMC Cancer · doi:10.1186/s12885-024-12907-1 · Cited by 7
Plasmacytoid dendritic cells alleviate allergic asthma via airway epithelial cell–dependent thymosin β4 expression
Li, Y., Chen, Z., Han, M., Duan, Z., Li, R., Cui, X., Ge, H., Shu, Y., Li, H., & He, R. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.01.047 · Cited by 7
Self-citation
Screening of biomarkers for liver adenoma in low-dose-rate γ-ray-irradiated mice
Sugihara, T., Tanaka, S., Braga-Tanaka, I., Murano, H., Nakamura-Murano, M., & Komura, J. (2018) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1439193 · Cited by 7
Breaking Immunosuppressive Barriers by Engineered Nanoplatforms for Turning Cold Tumor to Hot
Dong, J., Huang, Y., Zhou, Z., & Sun, M. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200020 · Cited by 7
Overexpression of fibroblast activation protein (FAP) in the stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostate
Pereira, F. C., Zheng, Q., Hicks, J. L., Roy, S., Jones, T., Pomper, M. G., Antony, L., Meeker, A. K., Yegnasubramanian, S., Marzo, A. M. D., et al. (2025) · Pathology · doi:10.1016/j.pathol.2024.12.637 · Cited by 6
Stromal Cells in Early Inflammation-Related Pancreatic Carcinogenesis—Biology and Its Potential Role in Therapeutic Targeting
Seidel, T., Ohri, N., Glaß, M., Sunami, Y., Müller, L. P., & Kleeff, J. H. (2025) · Cancers · doi:10.3390/cancers17091541 · Cited by 7
Novel insight into the role of Src family kinases in hepatocellular carcinoma and therapeutic potential
Yunlong, Z., Xie, L. X., Liu, B., Deng, Y., Li, P., Dai, Y., Liu, J., & Yi, C. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151970 · Cited by 6
Targeting cytokines: Reshaping the pancreatic tumor microenvironment
Bandi, D. S. R., Chabattula, S. C., Pynam, H., Joseph, J. T., Sarvesh, S., Nagaraju, G. P., & El‐Rayes, B. F. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.11.003 · Cited by 6
Research progress on immunotherapeutics for triple-negative breast cancer from a single-cell perspective
Yuan, Z., Liu, Z., Zhou, M., Wen, H., & Li, B. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105111 · Cited by 6
Self-citation
CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2–CCL2, CCR5–CCL5, CCR4–CCL17/22, CCR6–CCL20, CCR7–CCL19/21
Bahng, I. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1713123 · Cited by 6
Tumor Progression from a Fibroblast Activation Protein Perspective: Novel Diagnostic and Therapeutic Scenarios for Colorectal Cancer
Rossetti, M., Stanca, S., Frate, R. D., Bartoli, F., Marciano, A., Esposito, E., Fantoni, A., Erba, A. P., Lippolis, P. V., & Faviana, P. (2023) · Diagnostics · doi:10.3390/diagnostics13203199 · Cited by 5
The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of Cholangiocarcinoma
Zhang, Y., Yan, H., & Wu, J. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096267791231115101107 · Cited by 6
Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma
Liu, Y., Han, X.-L., Han, Y., Bi, J., Wu, Y., Xiang, D., Zhang, Y., Bi, W., Xu, M., & Li, J. (2024) · Gene · doi:10.1016/j.gene.2024.148286 · Cited by 6
Unraveling the role of cancer-associated fibroblasts in B cell lymphoma
Mukherjee, P., Ansell, S. M., & Mondello, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1451791 · Cited by 6
Cascade‐Responsive Nanoprodrug Disrupts Immune‐Fibroblast Communications for Potentiated Cancer Mechanoimmunotherapy
Guan, X., Shen, Y., Zhao, C., Li, X., Li, X., Lü, D., Wang, L., Liu, L., Wu, S., Huang, B., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500176 · Cited by 6
Radiation-induced FAP + fibroblasts are involved in keloid recurrence after radiotherapy
Gao, Y. H., Hou, X., Dai, Y., Yang, T., & Chen, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.957363 · Cited by 6
The role of extracellular vesicles in cholangiocarcinoma tumor microenvironment
Zhang, N., Shu, L., Liu, Z., Shi, A., Zhao, L., Huang, S., Sheng, G., Yan, Z., Song, Y. Y., Huang, F., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1336685 · Cited by 9
STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis
Sohrabi, S., Alipour, S., Ghahramanipour, Z., Masoumi, J., & Baradaran, B. (2024) · Bioimpacts · doi:10.34172/bi.30030 · Cited by 9
Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma
Bai, R.-L., Wang, N.-Y., Zhao, L., Zhang, Y., & Cui, J. (2021) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2021.08.012 · Cited by 6
Mesenchymal traits at the convergence of tumor-intrinsic and -extrinsic mechanisms of resistance to immune checkpoint blockers
Trono, P., Sistigu, A., Palermo, B., Ciliberto, G., & Nisticò, P. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170068 · Cited by 6
Extensive Intratumor Proteogenomic Heterogeneity Revealed by Multiregion Sampling in High-Grade Serous Ovarian Tumor SpecimensPreprint
Hunt, A. L., Bateman, N. W., Barakat, W., Makohon‐Moore, S. C., Hood, B. L., Conrads, K. A., Zhou, M., Calvert, V. S., Pierobon, M., Loffredo, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/761155 · Cited by 6
Crosstalk between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and immunotherapy
Wang, B., Zhao, X., Han, S., Xu, Y., & Li, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1691661 · Cited by 5
Exploratory Analysis of [68Ga]Ga-FAP-2286 PET/CT Quantitative Parameters for Predicting Response to [177Lu]Lu-FAP-2286 Therapy in Non-small Cell Lung Cancer
Fan, M., Guo, X., Liu, G., Tian, C., Zhao, J., & Chen, Y. (2025) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000006210 · Cited by 5
Stromal cells contribute to progression, recurrence, and metastasis in oral squamous cell carcinoma: a call for therapy
Hao, J., Zakershahrak, M., Ly, P., Le, A. D., Yu, W., Gates, J. C., & Chen, C. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07786-y · Cited by 5
Cytokines and cancer-associated fibroblasts
Hu, Y., Liang, J.-J., Duan, L., Zhu, J., Shan, G., Cheng, T., Wu, Y., Tan, L., & Zhan, C. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01801-x · Cited by 6
F AP deficiency enhances thermogenesis and attenuates metabolic inflammation in diet‐induced obesity
Wu, Y., Li, Y., Sun, M., Yu, F., Liu, H., Xu, J., & Tang, X. (2023) · Obesity · doi:10.1002/oby.23955 · Cited by 5
Identification of Cancer Associated Fibroblasts Related Genes Signature to Facilitate Improved Prediction of Prognosis and Responses to Therapy in Patients with Pancreatic Cancer
Zhou, Y. J., Lu, Y., Czubayko, F., Chen, J., Zheng, S., Mo, H., Liu, R., Weber, G. F., Grützmann, R., Pilarsky, C. P., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104876 · Cited by 5
Diverse cell types establish a pathogenic immune environment in peripheral neuropathy
Choi, J. Y., Strickland, A. M., Loo, H. Q., Dong, W., Barbar, L., Bloom, A. J., Sasaki, Y., Jin, S. C., DiAntonio, A., & Milbrandt, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03459-7 · Cited by 6
Natural small molecule bergapten ameliorates rheumatoid arthritis by targeting STAT3
Xie, J., Sun, S., Zhou, Z., Ma, X., Li, Q., Li, S., Luo, Y., Zhang, G., Hu, Y. M., Wang, G., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107878 · Cited by 5
[Progress on cancer associated fibroblasts in tumor immunoregulation].
Li, G., He, J., & Wang, Q. (2018) · PubMed Central · doi:10.3785/j.issn.1008-9292.2018.10.17 · Cited by 5
Immunohistochemical detection of cancer-associated fibroblasts in gastrointestinal cancer as a potential prognostic biomarker of survival: meta-analysis
Gu, J., Wang, C., Xu, X., Zhao, L., Zhou, J., Bai, C., & Sun, Z. (2020) · Translational Cancer Research · doi:10.21037/tcr-20-2365 · Cited by 5
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression
Cigliano, A., Strain, A. J., & Cadamuro, M. (2023) · Hepatoma Research · doi:10.20517/2394-5079.2023.09 · Cited by 5
PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2 ‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells
Liu, Q., Wu, N., & Hou, P. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15398 · Cited by 5
Tertiary Lymphoid Structures Are Associated with Favorable Clinical Outcomes and Negatively Correlated with Cancer-Associated Fibroblasts in Esophageal Cancer
Kunitomo, T., Noma, K., Nishiwaki, N., Nishimura, S., Takeda, Y., Matsumoto, H., Tatsuya, T., Kawasaki, K., Akai, M., Maeda, N., et al. (2025) · Cancers · doi:10.3390/cancers17203351 · Cited by 4
Extracellular Vesicle‐Based Antitumor Nanomedicines
Li, M., Liu, Y., Liu, F., Chen, Q., Xu, L., Cheng, Z., Tan, Y., & Liu, Z. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403903 · Cited by 5
Stromal PLAU mediates tumor progression and informs a novel therapeutic target in triple-negative breast cancer
Zou, J., Zhang, J., Li, Y., Yuan, B., Wang, Y., Qi, Y., Wang, Q., Qin, W., Yuan, X., & Xu, B. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03867-y · Cited by 4
The extracellular-matrix-remodeling capability exposes therapeutic vulnerability in a subset of renal cell carcinomas with tumor thrombi
Zhang, Q., Tan, Y., Liang, Q., Gu, L., Shi, Y. X., Huang, Y., Li, X., Qi, J., Peng, C., Wang, H., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.07.010 · Cited by 4
Self-citation
Immune Landscape of Intrahepatic Cholangiocarcinoma: Evasion and Therapeutic Insights
Porro, N., Spínola-Lasso, E., Marra, F., & Gentilini, A. (2025) · Immuno · doi:10.3390/immuno5030040 · Cited by 4
Osteoprotegerin (OPG) Upregulation Activates Breast Stromal Fibroblasts and Enhances Their Pro-Carcinogenic Effects through the STAT3/IL-6 Signaling
Al-Nasrallah, H. K., Al‐Ansari, M. M., & Aboussekhra, A. (2022) · Cells · doi:10.3390/cells11213369 · Cited by 4
Comprehensive analysis of the oncogenic and immunological role of FAP and identification of the ceRNA network in human cancers
Mai, W., Liu, Q., Li, J., Zheng, M., Yan, F., Liu, H., Lei, Y., Xu, J., & Xu, J. (2023) · Aging · doi:10.18632/aging.204707 · Cited by 4
The cellular triumvirate: fibroblasts entangled in the crosstalk between cancer cells and immune cells
Fergatova, A., & Affara, N. I. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1337333 · Cited by 4
Tumor-Agnostic Therapy—The Final Step Forward in the Cure for Human Neoplasms?
El-Sayed, M. M., Bianco, J. R., Li, Y., & Fábián, Z. (2024) · Cells · doi:10.3390/cells13121071 · Cited by 6
Interactions between fibroblasts and monocyte-derived cells in chronic lung injuries induced by real-ambient particulate matter exposure
Zeng, Y., Zhang, R., Yue, J., Li, D., Chen, L., Dong, G., Zhang, R., Niu, Y., Chen, W., & Chen, S. (2024) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2024.503807 · Cited by 4
Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments
Wei, P., & Zhao, L. (2024) · Hepatoma Research · doi:10.20517/2394-5079.2024.72 · Cited by 5
Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer
Patwardhan, M. V., Toh, K., Chiong, E., Rahmat, J. N., & Mahendran, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413296 · Cited by 4
Systematic review and meta-analysis of the prognostic role of fibroblast-activation protein in gastrointestinal cancers
Sunami, Y., Bai, R., Friedrichs, J., Ronellenfitsch, U., Kleeff, J. H., & Rebelo, A. (2024) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-24-374 · Cited by 4
Nanotechnology and Immunomodulators in Cancer
Volovat, C. D., Volovăț, S. R., & Agop, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-6379-6_5 · Cited by 4
Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components
Caligiuri, A., Parola, M., Marra, F., Cannito, S., & Gentilini, A. (2023) · Hepatoma Research · doi:10.20517/2394-5079.2023.23 · Cited by 4
Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy
Olivera, I., Luri‐Rey, C., Teijeira, Á., Eguren‐Santamaría, I., Gomis, G., Palencia, B., Berraondo, P., & Melero, I. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3653 · Cited by 4
FAP expression dynamics and role in silicosis: Insights from epidemiological and experimental models
Deng, X., Cheng, Z., Li, Y., Duan, M., Qi, J., Hao, C., & Yao, W. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124311 · Cited by 4
Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity
Motofei, I. G. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2020243 · Cited by 5
Peaceful Existence of Tumor Cells with Their Non-malignant Neighbors: The Trade of Tumor Cells with Tumor Microenvironment
Maali, A., Sarfi, M., Mirzakhani, M., Goodarzi, G., Maghsoudi, H., Maniati, M., Tehrani, S. S., & Qujeq, D. (2020) · Current Chemical Biology · doi:10.2174/2212796814999200925162943 · Cited by 4
Conversion of cancer-associated fibroblasts from pro- to antitumor improves the sensitivity of pancreatic cancer to chemotherapeuticsPreprint
Iida, T., Mizutani, Y., Esaki, N., Ponik, S. M., Burkel, B. M., Weng, L., Kuwata, K., Masamune, A., Ishihara, S., Haga, H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.29.450327 · Cited by 4
Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progress
Homedan, A., Pandya, D. N., Schnicker, N., & Wadas, T. J. (2025) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-025-00356-5 · Cited by 3
Cancer-associated fibroblasts in lymph node metastasis: Insights and therapeutic strategies
Yuan, J., Zhang, R., & Geng, Z. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003833 · Cited by 3
Superior mucoepidermoid carcinoma detection with ⁶⁸Ga-FAPI PET/CT reflects FAP-α expression and MAML2 fusion status
Jianbo, Y. A. N. G., Liu, M., Tang, H., Li, J., Chen, J., & Xie, Y. (2026) · Scientific Reports · doi:10.1038/s41598-025-34528-9 · Cited by 3
Pleiotropic mechanisms of cancer-associated fibroblast-mediated resistance in hepatocellular carcinoma: emerging therapeutic vulnerabilities and targeting strategies
Xie, W., Fang, J., Wang, Z., Li, X., Du, J., & Ling, C. (2026) · Cancer Gene Therapy · doi:10.1038/s41417-026-01007-w · Cited by 3
CXCL1-overexpressing cancer-associated fibroblasts stimulate hepatocellular carcinoma progression via neutrophil recruitment, NET formation, and immune suppression
Bi, B., Tang, L., Liang, R., Wu, H., Huang, Q., & Pan, L. (2026) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-026-04304-3 · Cited by 3
In vivo exposure to CXCL12-high CAFs and chronic CXCL12 stimulation in vitro is sufficient to enhance metastasis of ER-positive breast cancer
Miller, P. C., Sharma, U., Tao, J., Sun, J., Medina-Saenz, K., Picon‐Ruiz, M., Morata‐Tarifa, C., Bare, S., Slingerland, J. M., El‐Ashry, D., et al. (2026) · Breast Cancer Research and Treatment · doi:10.1007/s10549-026-07970-0 · Cited by 3
Visualization of Cancer Cell-Derived Exosome-Induced Fibroblast Phenotypic Transformation
Yin, S., Chen, F., Peng, B., Shi, Y., Lu, Q., Zhu, X., Li, H., & Zhang, Y. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c06175 · Cited by 3
Self-citation
Loss of primary cilia promotes EphA2 ‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment
Cho, J. G., Hah, Y., Yun, E., Ka, H. I., Lee, A., Han, S., Lee, D., Kim, S. W., Park, J. H., Kwon, B. S., et al. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70057 · Cited by 3
“A perfect pair”: extracellular vesicle-based novel strategies for precise cancer diagnosis and effective treatment
Zhao, H., Du, F., Guo, R., & Qiu, L. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01154j · Cited by 3
Polymeric Nanoparticle-Mediated Photodynamic Therapy: A Synergistic Approach for Glioblastoma Treatment
Al‐Dhubiab, B. E., & Almuqbil, R. M. (2025) · Pharmaceuticals · doi:10.3390/ph18071057 · Cited by 3
Introduction of Z-GP scaffold into procarbazine reduces spermatoxicity and myelosuppression
Wang, R., Zhang, C., Zheng, C., Li, H., Xie, X., Jin, Y., Liu, Z., & Chen, H. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.11.011 · Cited by 3
Immunotherapy for Pancreatic Cancer
Sunami, Y., Rieder, S., Michl, P., & Kleeff, J. H. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_223-1 · Cited by 3
A model‐based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific antibodies in immuno‐oncology
Sánchez, J., Claus, C., Albrecht, R., Gaillard, B., Marinho, J. C. L., McIntyre, C., Tanos, T., Boehnke, A., Friberg, L. E., Jönsson, S., et al. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13065 · Cited by 3
FAP overexpression induce Epithelial-Mesenchymal Transition (EMT) in oral squamous cell carcinoma by down-regulating DPP9 genePreprint
Wu, Q., Zhao, M., Huang, G., Zheng, Z., Zeng, W., & Lv, X. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/765743 · Cited by 3
A Cancer-Associated Fibroblast Classification Framework for Single-Cell DataPreprint
Cords, L., Tietscher, S., Anzeneder, T., Langwieder, C., Rees, M., de Souza, N., & Bodenmiller, B. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.14.520398 · Cited by 3
Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early pre-neoplastic pancreatic lesionsPreprint
Carpenter, E. S., Elhossiny, A. M., Kadiyala, P., Li, J., McGue, J. J., Griffith, B. D., Zhang, Y., Edwards, J., Nelson, S., Lima, F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.13.523300 · Cited by 3
Unveiling the Role of the Cellular Tumor Microenvironment and the Therapeutic Targets it Provides in Cutaneous T-Cell Lymphoma
Chinas, N. A., Kaliampou, S., & Nikolaou, V. A. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01646-6 · Cited by 2

Authors: Yang, X., Lin, Y., Shi, Y., Li, B., Liu, W., Yin, W., Dang, Y., Chu, Y., Fan, J., & He, R.
Affiliations: Shanghai Medical College of Fudan University (CN)
ORCID: Yang, Xuguang
Lin, Yuli
Li, Bingji
Liu, Weiren
Yin, Wei
Dang, Yongjun
Chu, Yiwei
Fan, Jia
He, Rui
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2016-07-14
Volume: 76
Issue: 14
Pages: 4124-4135
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-15-2973
OpenAlex: W2400022769
Cited by: 748
References: 44
Citations by year: 2026: 66 · 2025: 101 · 2024: 107 · 2023: 115 · 2022: 91 · 2021: 95 · 2020: 67 · 2019: 47 · 2018: 31 · 2017: 25 · 2016: 3
FWCI: 19.03
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Funders: NSFC (813220437, 81471555, 81272389)
National Key Sci-Tech Project (2012ZX10002011-002)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords: fibroblast activation protein, cancer-associated fibroblasts, tumor microenvironment, STAT3 signaling, MCP-1, CCR2, myeloid-derived suppressor cells, uPAR, desmoplasia, intrahepatic cholangiocarcinoma, liver cancer, immunosuppression, tumor stroma
MeSH terms: Cancer-Associated Fibroblasts, Fibroblast Activation Protein Alpha, Animals, Cell Movement, Female, Immune Tolerance, Membrane Proteins, Mice, Inbred C57BL, Endopeptidases, Serine Endopeptidases, Signal Transduction, Gelatinases, Chemokine CCL2, STAT3 Transcription Factor, Mice, Focal Adhesion Protein-Tyrosine Kinases, Janus Kinase 2, Receptors, Urokinase Plasminogen Activator, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks